The French domestic “sanitary pass” did not solve Covid-19 vaccination inequities in France

Débarre Florence, Lecoeur Emmanuel, Guimier Lucie, Jauffret-Roustide Marie, Jannot Anne-Sophie
doi: https://doi.org/10.1101/2022.01.03.22268676

Abstract

The French sanitary pass led to an increase in vaccination rates in France, but local heterogeneities in vaccination rates remain. To identify potential determinants of these heterogeneities and how the French sanitary pass influenced them, we used a data-driven approach on exhaustive nationwide data, gathering 181 socio-economic and geographic factors. Our analysis reveals that, both before and after the introduction of the French sanitary pass, factors with the largest impact are related to poverty, with the most deprived areas having greater than 10 times the odds of being among the districts with lower vaccination rates.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

EL received funding to match socio-economic data with medical data from AP-HP Centre Universite de Paris.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study involves only openly available data: - INSEE: https://www.insee.fr/fr/statistiques/5359146#consulter - Assurance Maladie: datavaccin-covid.ameli.fr/explore/dataset/donnees-devaccination-par-epci/https://datavaccin-covid.ameli.fr/explore/dataset/donnees-devaccination-par-epci/https://datavaccin-covid.ameli.fr/explore/dataset/donnees-de-vaccination-parcommune/information/ The data are published by official French institutions, are only available in aggregated format, and therefore are not individual data.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
Posted January 05, 2022.
Download PDF
Data/Code
Email
The French domestic “sanitary pass” did not solve Covid-19 vaccination inequities in France
Débarre Florence, Lecoeur Emmanuel, Guimier Lucie, Jauffret-Roustide Marie, Jannot Anne-Sophie
medRxiv 2022.01.03.22268676; doi: https://doi.org/10.1101/2022.01.03.22268676
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area